Pasithea Income Tax Expense from 2010 to 2025

KTTAW Stock  USD 0.02  0  9.89%   
Pasithea Therapeutics Income Tax Expense yearly trend continues to be fairly stable with very little volatility. Income Tax Expense is likely to outpace its year average in 2025. During the period from 2010 to 2025, Pasithea Therapeutics Income Tax Expense regression line of quarterly data had mean square error of 24290.2 T and geometric mean of  291,725. View All Fundamentals
 
Income Tax Expense  
First Reported
2010-12-31
Previous Quarter
522 M
Current Value
548.1 M
Quarterly Volatility
205.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pasithea Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pasithea Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 783 K, Other Operating Expenses of 9.9 M or Total Operating Expenses of 15 B, as well as many indicators such as Price To Sales Ratio of 36.39, Dividend Yield of 83.34 or PTB Ratio of 2.0E-4. Pasithea financial statements analysis is a perfect complement when working with Pasithea Therapeutics Valuation or Volatility modules.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Latest Pasithea Therapeutics' Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of Pasithea Therapeutics Corp over the last few years. It is Pasithea Therapeutics' Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pasithea Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Slightly volatile
   Income Tax Expense   
       Timeline  

Pasithea Income Tax Expense Regression Statistics

Arithmetic Mean95,152,945
Geometric Mean291,725
Coefficient Of Variation216.07
Mean Deviation154,817,999
Median(61,476)
Standard Deviation205,598,266
Sample Variance42270.6T
Range549M
R-Value0.68
Mean Square Error24290.2T
R-Squared0.46
Significance0
Slope29,405,698
Total Sum of Squares634059.7T

Pasithea Income Tax Expense History

2025548.1 M
2024522 M
2023453.9 M
2022-880 K
2021 508.0

About Pasithea Therapeutics Financial Statements

Pasithea Therapeutics investors use historical fundamental indicators, such as Pasithea Therapeutics' Income Tax Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pasithea Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Income Tax Expense522 M548.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pasithea Stock Analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.